Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIOSPIR: Tiotropium Respimat vs HandiHaler in COPD
NCT01126437Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 51
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started May 2010; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01126437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01126437.